Takahiro Takano
Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Astrocytes | 22 | 2000 | 62 |
Why?
| Calcium Signaling | 10 | 2000 | 52 |
Why?
| Cortical Spreading Depression | 2 | 2007 | 3 |
Why?
| Glutamic Acid | 4 | 2001 | 66 |
Why?
| Calcium | 9 | 2000 | 208 |
Why?
| Cerebrovascular Circulation | 4 | 2003 | 62 |
Why?
| Adenosine Triphosphate | 10 | 2000 | 121 |
Why?
| Migraine Disorders | 1 | 2009 | 11 |
Why?
| Brain | 8 | 2003 | 305 |
Why?
| Vasodilation | 2 | 2005 | 30 |
Why?
| Brain Neoplasms | 3 | 2001 | 116 |
Why?
| Glioma | 4 | 2000 | 51 |
Why?
| Brain Ischemia | 1 | 2008 | 45 |
Why?
| Ethylenediamines | 1 | 2006 | 4 |
Why?
| Animals | 30 | 2000 | 1031 |
Why?
| Acetic Acids | 1 | 2006 | 31 |
Why?
| Magnesium | 1 | 2006 | 69 |
Why?
| Anoxia | 1 | 2007 | 85 |
Why?
| Blood Vessels | 1 | 2007 | 65 |
Why?
| Cell Size | 1 | 2005 | 68 |
Why?
| Ion Channels | 1 | 2005 | 61 |
Why?
| Mice | 15 | 2003 | 623 |
Why?
| Alzheimer Disease | 1 | 2007 | 71 |
Why?
| Connexin 43 | 5 | 2002 | 14 |
Why?
| Neurons | 8 | 2001 | 195 |
Why?
| Rats | 15 | 2000 | 530 |
Why?
| Mice, Transgenic | 5 | 2005 | 209 |
Why?
| Amino Acid Transport System X-AG | 1 | 2001 | 6 |
Why?
| Symporters | 1 | 2001 | 11 |
Why?
| Microcirculation | 4 | 2003 | 49 |
Why?
| Disease Models, Animal | 6 | 2004 | 349 |
Why?
| Receptors, Purinergic P2 | 4 | 2003 | 13 |
Why?
| Purinergic P2 Receptor Antagonists | 3 | 2004 | 8 |
Why?
| Brain Edema | 2 | 2007 | 26 |
Why?
| Adenosine | 2 | 2007 | 57 |
Why?
| Glioblastoma | 1 | 2009 | 44 |
Why?
| Afferent Pathways | 2 | 2006 | 24 |
Why?
| Radiosurgery | 1 | 2009 | 24 |
Why?
| Spinal Cord Injuries | 2 | 2004 | 34 |
Why?
| Cerebral Cortex | 3 | 2002 | 108 |
Why?
| Epilepsy | 2 | 2005 | 49 |
Why?
| Rats, Sprague-Dawley | 6 | 2003 | 257 |
Why?
| Patch-Clamp Techniques | 4 | 2002 | 47 |
Why?
| Cell Communication | 3 | 2002 | 72 |
Why?
| Male | 10 | 2001 | 1553 |
Why?
| Pericytes | 2 | 2003 | 10 |
Why?
| Aquaporin 4 | 1 | 2010 | 9 |
Why?
| Capillaries | 2 | 2007 | 47 |
Why?
| Acupuncture Analgesia | 1 | 2010 | 5 |
Why?
| Receptors, Purinergic P1 | 1 | 2010 | 19 |
Why?
| Luminescent Proteins | 2 | 2007 | 67 |
Why?
| Electroencephalography | 2 | 2007 | 88 |
Why?
| Reperfusion Injury | 1 | 2010 | 22 |
Why?
| TRPM Cation Channels | 1 | 2009 | 3 |
Why?
| Rosaniline Dyes | 1 | 2009 | 8 |
Why?
| Membrane Potentials | 2 | 2007 | 99 |
Why?
| Humans | 13 | 2000 | 1856 |
Why?
| Peripheral Nervous System Diseases | 1 | 2010 | 45 |
Why?
| Ischemia | 1 | 2009 | 65 |
Why?
| Up-Regulation | 2 | 2006 | 183 |
Why?
| Exocytosis | 2 | 2005 | 15 |
Why?
| Endothelium, Vascular | 2 | 2002 | 139 |
Why?
| Ischemic Preconditioning | 1 | 2008 | 9 |
Why?
| Gap Junctions | 3 | 2002 | 15 |
Why?
| Tremor | 1 | 2007 | 14 |
Why?
| Stroke | 1 | 2010 | 59 |
Why?
| Deep Brain Stimulation | 1 | 2007 | 8 |
Why?
| Potassium | 1 | 2009 | 98 |
Why?
| Laser-Doppler Flowmetry | 1 | 2007 | 18 |
Why?
| Lysosomes | 1 | 2007 | 38 |
Why?
| Female | 7 | 2004 | 1643 |
Why?
| Absorptiometry, Photon | 1 | 2007 | 26 |
Why?
| Calcium Channels | 1 | 2009 | 52 |
Why?
| Immunohistochemistry | 3 | 2002 | 355 |
Why?
| Cytoplasm | 1 | 2007 | 108 |
Why?
| NAD | 1 | 2007 | 41 |
Why?
| Pain | 1 | 2010 | 191 |
Why?
| Purines | 1 | 2006 | 23 |
Why?
| Touch | 1 | 2006 | 10 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2006 | 14 |
Why?
| Mechanoreceptors | 1 | 2006 | 9 |
Why?
| Diagnostic Imaging | 1 | 2007 | 66 |
Why?
| Somatosensory Cortex | 1 | 2006 | 24 |
Why?
| Cyclooxygenase 1 | 1 | 2005 | 41 |
Why?
| Excitatory Amino Acid Antagonists | 2 | 2001 | 21 |
Why?
| Luminescent Measurements | 2 | 2001 | 35 |
Why?
| Connexins | 2 | 2002 | 18 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 2001 | 38 |
Why?
| Gene Expression Profiling | 1 | 2007 | 138 |
Why?
| Pyridoxal Phosphate | 1 | 2004 | 8 |
Why?
| Rats, Wistar | 2 | 2001 | 75 |
Why?
| Neoplasm Transplantation | 2 | 2001 | 67 |
Why?
| Tumor Cells, Cultured | 3 | 2000 | 233 |
Why?
| Oxygen | 1 | 2007 | 179 |
Why?
| Tamoxifen | 2 | 2000 | 38 |
Why?
| Image Processing, Computer-Assisted | 1 | 2005 | 138 |
Why?
| Magnetic Resonance Imaging | 2 | 2005 | 294 |
Why?
| Mice, Inbred C57BL | 4 | 2007 | 318 |
Why?
| Receptors, Glutamate | 1 | 2002 | 13 |
Why?
| Stem Cells | 1 | 2006 | 107 |
Why?
| Neuroblastoma | 1 | 2003 | 36 |
Why?
| Glutamate Plasma Membrane Transport Proteins | 1 | 2001 | 4 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 71 |
Why?
| Memantine | 1 | 2001 | 8 |
Why?
| Dizocilpine Maleate | 1 | 2001 | 10 |
Why?
| Respiratory Mucosa | 1 | 2002 | 39 |
Why?
| Central Nervous System | 1 | 2002 | 77 |
Why?
| Signal Transduction | 3 | 2002 | 313 |
Why?
| Neoplasms, Experimental | 1 | 2002 | 72 |
Why?
| Membrane Proteins | 1 | 2005 | 233 |
Why?
| Rats, Inbred F344 | 1 | 2001 | 80 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2000 | 30 |
Why?
| Salvage Therapy | 1 | 2009 | 37 |
Why?
| Nucleotidases | 2 | 2006 | 11 |
Why?
| Cell Division | 1 | 2001 | 273 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 89 |
Why?
| Disease-Free Survival | 1 | 2009 | 102 |
Why?
| Receptors, Purinergic P2X7 | 2 | 2004 | 9 |
Why?
| Carrier Proteins | 1 | 2001 | 177 |
Why?
| Time Factors | 3 | 2008 | 896 |
Why?
| Transfection | 3 | 2002 | 237 |
Why?
| Hippocampus | 2 | 2005 | 83 |
Why?
| Glial Fibrillary Acidic Protein | 2 | 2003 | 37 |
Why?
| Mice, Knockout | 2 | 2008 | 265 |
Why?
| Anticonvulsants | 2 | 2005 | 61 |
Why?
| Electrophysiology | 2 | 2004 | 101 |
Why?
| Receptors, Purinergic | 2 | 2000 | 6 |
Why?
| Synaptic Transmission | 2 | 2002 | 58 |
Why?
| Breast Neoplasms | 1 | 2000 | 185 |
Why?
| Cell Survival | 2 | 2003 | 229 |
Why?
| Animals, Newborn | 2 | 2002 | 175 |
Why?
| Cells, Cultured | 3 | 2002 | 447 |
Why?
| Models, Biological | 2 | 2007 | 410 |
Why?
| Retrospective Studies | 1 | 2009 | 653 |
Why?
| Adult | 3 | 2000 | 1317 |
Why?
| Aged | 2 | 2009 | 988 |
Why?
| Fluorescent Dyes | 2 | 2002 | 115 |
Why?
| Aged, 80 and over | 1 | 2009 | 599 |
Why?
| Osmosis | 1 | 2010 | 14 |
Why?
| Photons | 1 | 2010 | 13 |
Why?
| Cytosol | 2 | 2000 | 79 |
Why?
| Constriction | 1 | 2010 | 18 |
Why?
| Treatment Outcome | 1 | 2009 | 661 |
Why?
| Peroxynitrous Acid | 1 | 2010 | 8 |
Why?
| Middle Aged | 2 | 2009 | 1161 |
Why?
| Sciatica | 1 | 2010 | 6 |
Why?
| Water | 1 | 2010 | 85 |
Why?
| Edema | 1 | 2010 | 67 |
Why?
| Pain Management | 1 | 2010 | 32 |
Why?
| Statistics, Nonparametric | 1 | 2010 | 141 |
Why?
| Hominidae | 1 | 2009 | 10 |
Why?
| Pan troglodytes | 1 | 2009 | 13 |
Why?
| Indicators and Reagents | 1 | 2009 | 79 |
Why?
| Saimiri | 1 | 2009 | 22 |
Why?
| RNA Interference | 1 | 2009 | 75 |
Why?
| Recovery of Function | 1 | 2009 | 91 |
Why?
| Retina | 1 | 2010 | 60 |
Why?
| Kainic Acid | 1 | 2008 | 17 |
Why?
| Amyloid beta-Protein Precursor | 1 | 2008 | 15 |
Why?
| Receptor, Adenosine A1 | 1 | 2007 | 8 |
Why?
| Species Specificity | 1 | 2009 | 186 |
Why?
| Spinal Cord | 1 | 2009 | 94 |
Why?
| Neuroprotective Agents | 1 | 2009 | 60 |
Why?
| Dendrites | 1 | 2008 | 24 |
Why?
| Macaca mulatta | 1 | 2009 | 71 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2008 | 18 |
Why?
| Thalamus | 1 | 2007 | 23 |
Why?
| Valproic Acid | 1 | 2008 | 26 |
Why?
| Analysis of Variance | 1 | 2010 | 339 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 48 |
Why?
| Cerebellum | 1 | 2007 | 59 |
Why?
| Amino Acids | 1 | 2008 | 108 |
Why?
| Hydrogen Peroxide | 1 | 2008 | 75 |
Why?
| Green Fluorescent Proteins | 1 | 2008 | 105 |
Why?
| Multipotent Stem Cells | 1 | 2006 | 10 |
Why?
| RNA, Small Interfering | 1 | 2008 | 116 |
Why?
| Mitogens | 1 | 2006 | 31 |
Why?
| Behavior, Animal | 1 | 2008 | 77 |
Why?
| Autocrine Communication | 1 | 2006 | 24 |
Why?
| Vibrissae | 1 | 2006 | 7 |
Why?
| Excitatory Postsynaptic Potentials | 1 | 2006 | 14 |
Why?
| Axons | 1 | 2007 | 66 |
Why?
| Physical Stimulation | 1 | 2006 | 28 |
Why?
| Receptors, AMPA | 1 | 2006 | 17 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2006 | 7 |
Why?
| Mice, Inbred Strains | 1 | 2006 | 118 |
Why?
| Photolysis | 1 | 2005 | 11 |
Why?
| Reaction Time | 1 | 2006 | 81 |
Why?
| Enzyme Inhibitors | 1 | 2008 | 216 |
Why?
| Young Adult | 1 | 2009 | 380 |
Why?
| Nerve Tissue Proteins | 1 | 2008 | 128 |
Why?
| Oxazines | 1 | 2004 | 16 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 65 |
Why?
| Receptors, Purinergic P2Y2 | 1 | 2003 | 4 |
Why?
| Action Potentials | 1 | 2005 | 77 |
Why?
| Basement Membrane | 1 | 2003 | 31 |
Why?
| Diffusion | 1 | 2003 | 49 |
Why?
| Ionophores | 1 | 2003 | 15 |
Why?
| Microscopy, Confocal | 1 | 2004 | 105 |
Why?
| Estrogen Antagonists | 1 | 2003 | 13 |
Why?
| Genes, Dominant | 1 | 2003 | 68 |
Why?
| Blood-Brain Barrier | 1 | 2003 | 63 |
Why?
| Cell Aggregation | 1 | 2002 | 25 |
Why?
| Permeability | 1 | 2002 | 52 |
Why?
| Extracellular Space | 1 | 2002 | 58 |
Why?
| Child, Preschool | 1 | 2009 | 554 |
Why?
| Umbilical Veins | 1 | 2002 | 46 |
Why?
| Gene Expression Regulation | 1 | 2008 | 277 |
Why?
| HeLa Cells | 1 | 2003 | 107 |
Why?
| Neoplasm Invasiveness | 1 | 2002 | 105 |
Why?
| Structure-Activity Relationship | 1 | 2002 | 124 |
Why?
| Ultraviolet Rays | 1 | 2003 | 76 |
Why?
| Antibodies | 1 | 2002 | 159 |
Why?
| Purinergic Agonists | 1 | 2000 | 2 |
Why?
| Estrogen Receptor Modulators | 1 | 2000 | 4 |
Why?
| Purinergic Antagonists | 1 | 2000 | 3 |
Why?
| Suramin | 1 | 2000 | 9 |
Why?
| Cell Adhesion | 1 | 2002 | 113 |
Why?
| Mutagenesis, Site-Directed | 1 | 2002 | 126 |
Why?
| Cell Differentiation | 1 | 2006 | 262 |
Why?
| Cell Death | 1 | 2000 | 94 |
Why?
| Child | 1 | 2009 | 749 |
Why?
| Adolescent | 1 | 2009 | 891 |
Why?
| Oxidative Stress | 1 | 2003 | 119 |
Why?
| Kinetics | 1 | 2002 | 349 |
Why?
| Dose-Response Relationship, Drug | 1 | 2002 | 431 |
Why?
| Cell Line | 1 | 2003 | 375 |
Why?
| Apoptosis | 1 | 2004 | 265 |
Why?
|
|
Takano's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
